Last reviewed · How we verify
NCT05499468: POL
Evaluating a Physician Opinion Leader Intervention to Increase Utilization of Coaching/Therapy During Residency
NA trial testing Popular-Opinion Leader-led encouragement during training meetings and informal conversation in Workplace Culture in 493 participants. Completed in 11 October 2022.
11 October 2022
Quick facts
| Lead sponsor | Stanford University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 493 |
| Start date | 30 August 2022 |
| Primary completion | 11 October 2022 |
| Estimated completion | 11 October 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Popular-Opinion Leader-led encouragement during training meetings and informal conversation
Conditions studied
- Workplace Culture — all drugs for Workplace Culture →
- Help-Seeking Behavior — all drugs for Help-Seeking Behavior →
- Social Stigma — all drugs for Social Stigma →
- Education, Medical, Continuing — all drugs for Education, Medical, Continuing →
Sponsor
Stanford University
Who can join
Eligibility, any sex, with Workplace Culture or Help-Seeking Behavior. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Investigators will assess the efficacy of a physician popular opinion leader-led intervention to increase awareness and utilization of existing evidence-based coaching or therapy among post-graduate clinical trainees at Stanford.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05499468
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Stanford University trials
Trials by the same sponsor.
- NCT05945147 — Ketamine and Midazolam Infusions for CRPS: Feasibility Study · Phase 2 · withdrawn
- NCT04225949 — Patients Understanding of PROM Graphs · NA · withdrawn
- NCT06273098 — School-Based Bladder Health Intervention · NA · withdrawn
- NCT04652635 — Management of Nailbed Injuries · NA · withdrawn
- NCT05443503 — Stanford Spine Keeper - Managing Your Low Back Pain · NA · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05499468 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Stanford University
- Last refreshed: 23 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05499468.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing